Managing Medical Risk in Patients Seeking Psilocybin Therapy with Reid Robison, MD, MBA

Managing Medical Risk in Patients Seeking Psilocybin Therapy with Reid Robison, MD, MBA

Author: Lynn Marie Morski, MD, JD July 5, 2023 Duration: 46:09
Psychedelic Medicine Podcast with Dr. Lynn Marie Morski
HealthHealth & FitnessFitnessMedicineMental

In this episode of the Psychedelic Medicine Podcast, Dr. Reid Robison joins to discuss managing medical risk in patients seeking psilocybin therapy. Dr. Robison is a board-certified psychiatrist and Chief Clinical Officer at Numinus, overseeing the company's psychedelic and mental health services across the US and Canada. He has led over 200 clinical trials in neuropsychiatry, including the MAPS-sponsored MDMA-assisted therapy for eating disorders study, and several other psychedelic studies with psilocybin, LSD and DMT.

In this conversation, Dr. Robison begins by sharing how researchers have been determining guidelines for managing medical risks associated with psilocybin and how this guidance may shift as research continues in real-world settings at larger scales. He also discusses the intricacies of psilocybin's pharmacokinetics and how the substance interacts with common psychiatric medications such as SSRI antidepressants. In closing, Dr. Robison emphasizes the importance of keeping a close eye on potential psychological risks of psilocybin and other psychedelics, especially amid the excitement stemming from the incredible potential of these medicines.

 

In this episode:

  • The emerging medical indications for psilocybin therapy
  • How the research into psilocybin has developed in the past few years
  • The pharmacokinetics of psilocybin
  • Medication interactions with psilocybin
  • Risks of serotonin syndrome
  • Absolute vs relative contraindications
  • Psilocybin's effect on QT interval and heart valves
  • The Psychedelic Medicine Association's "Psilcobyin-Informed Clinicians" database comprised of practitioners who have completed the course

 

Quotes:

"There's a lot to learn [about the interaction of psilocybin and SSRIs] and it's a little bit unpredictable. And some people anecdotally would say that their SSRI interfered with their trip or diminished the experience and others would say it did not." [26:22]

"Psychological risks are nontrivial, including the risk of a difficult experience—something that may even need some mental health treatment afterwards, something that may be meaningful, nontrivial for the individual for a while, and can coexist with the mystical experience. And having the most meaningful experience of your life can coincide with the most difficult." [40:43]

 

Links:

Course: Managing Medical Risk in Patients Seeking Psilocybin Therapy

Dr. Robison's website

Dr. Robison on Twitter

Dr. Robison on Instagram

Numinus website

Previous episode: Psychedelics for Eating Disorders with Reid Robison

Psychedelic Medicine Association

Porangui


Exploring the frontier of mind and medicine, the Psychedelic Medicine Podcast with Dr. Lynn Marie Morski delves into the complex world of psychedelic substances and their potential to heal. Hosted by Lynn Marie Morski, a physician and attorney, this podcast navigates the intricate intersection of cutting-edge science, clinical practice, and evolving policy. Each episode brings a grounded, expert perspective to conversations about psilocybin, MDMA, ketamine, LSD, ayahuasca, ibogaine, and other compounds, moving beyond hype to examine the real-world implications of this therapeutic renaissance. Listeners will hear detailed discussions on the latest peer-reviewed research, practical insights from medical professionals integrating these approaches, and thoughtful analysis of the legal landscape shaping access. The dialogue is rooted in a commitment to safety, ethics, and evidence, offering a clear-eyed look at both the profound promise and the challenges inherent in psychedelic medicine. Whether you're a healthcare provider, a patient, a researcher, or simply intellectually curious, this podcast provides an essential, nuanced resource for understanding how these ancient and modern substances are reshaping perspectives on mental health, consciousness, and treatment. It’s a space for serious inquiry, where complex questions about healing, neuroscience, and society are met with informed, accessible conversation.
Author: Language: English Episodes: 100

Official website RSS
instagramlinkedin
Psychedelic Medicine Podcast with Dr. Lynn Marie Morski
Podcast Episodes
Ketamine: The Promise and the Peril with Mark Braunstein, DO [not-audio_url] [/not-audio_url]

Duration: 38:17
In this episode of the Psychedelic Medicine Podcast, Mark Braunstein, DO joins to discuss the promise and the peril of ketamine. Dr. Braunstein graduated medical school in 1997 then completed a General Psychiatry Residen…
5-MeO-DMT for Trauma and PTSD with Steve Rio [not-audio_url] [/not-audio_url]

Duration: 47:47
In this episode of the Psychedelic Medicine Podcast, Steve Rio joins to discuss 5-MeO-DMT for Trauma and PTSD. Steve is a psychedelic facilitator and Co-Founder of Enfold, which offers a groundbreaking psychospiritual mo…
Ketamine-Assisted Couples Therapy with Chandra Khalifian, PhD [not-audio_url] [/not-audio_url]

Duration: 32:11
In this episode of the Psychedelic Medicine Podcast, Chandra Khalifian, PhD joins to explore ketamine-assisted couples therapy. Dr. Chandra Khalifian is a clinical psychologist, researcher, educator and Co-CEO of Enamory…
Psychedelics and Seizure Disorders with Evan Lewis, MD, FRCPC [not-audio_url] [/not-audio_url]

Duration: 32:57
In this episode of the Psychedelic Medicine Podcast, Dr. Evan Cole Lewis joins to explore the topic of psychedelics and seizure disorders. Dr. Lewis is a Canadian Neurologist and holds an appointment as Assistant Profess…

«12345678910»